Viridian Therapeutics, Inc. (VRDN) Profit Margins
Over the twelve months to 2026-06-30, Viridian Therapeutics, Inc. (VRDN) had operating margin -569.7%, net margin -544.1%, free cash flow margin -471.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VRDNViridian Therapeutics, Inc.Follow VRDN — free
—
Price chart with a free account
- Market cap
- 2.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 10 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 48.1% | 56.7% | 26.7% | — | — | — | — | — | — | — | — | — | — | |
| Operating margin | -105.9% | -196.1% | -488.6% | -662.8% | -394.5% | -941.0% | -10512.4% | -2690.8% | -7579.2% | -81035.0% | -99018.2% | -512.9% | -569.7% | |
| Net margin | -121.7% | -198.5% | -496.8% | -662.3% | -390.0% | -938.6% | -10544.3% | -2680.2% | -7329.2% | -75711.5% | -89387.1% | -483.6% | -544.1% | |
| FCF margin | -38.2% | -123.0% | -431.6% | -709.8% | -325.4% | -810.1% | -2840.1% | -1853.5% | -5340.6% | -58938.9% | -77096.0% | -390.8% | -471.0% |
USD billions · SEC XBRL
Viridian Therapeutics, Inc. — questions
- What is Viridian Therapeutics, Inc.'s operating margin?
- -569.7% over the twelve months to 2026-06-30.
- What is Viridian Therapeutics, Inc.'s net profit margin?
- -544.1% over the twelve months to 2026-06-30.
Every figure on this page comes from Viridian Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.